Article Versions Notes

Ledov VA, Romanenko VV, Golovina ME, Alkhazova BI, Kovalchuk AL, Aparin PG. A Candidate Ac₃-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized Phase 2 Clinical Trial. Vaccines. 2025; 13(3):209. https://doi.org/10.3390/vaccines13030209

Ledov, Vladimir A., Victor V. Romanenko, Marina E. Golovina, Biana I. Alkhazova, Alexander L. Kovalchuk, and Petr G. Aparin. 2025. "A Candidate Ac₃-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized Phase 2 Clinical Trial" Vaccines 13, no. 3: 209. https://doi.org/10.3390/vaccines13030209

Ledov, V. A., Romanenko, V. V., Golovina, M. E., Alkhazova, B. I., Kovalchuk, A. L., & Aparin, P. G. (2025). A Candidate Ac₃-S-LPS Vaccine Against S. flexneri 1b, 2a, 3a, 6, and Y Activates Long-Lived Systemic and Mucosal Immune Responses in Healthy Volunteers: Results of an Open-Label, Randomized Phase 2 Clinical Trial. Vaccines, 13(3), 209. https://doi.org/10.3390/vaccines13030209